LYSOBACT DUO

Compressed lozenge, 20mg/1.5mg
OTCActive license

Active substance (INN)

cetylpyridiniumlysozyme

Pharmaceutical form

Pharmaceutical formCompressed lozenge
Strength20mg/1.5mg
PackagingUkupno 20 komprimovanih lozengi u blisteru (2x10) u kartonskoj kutiji
ManufacturerBosnalijek d.d., Bosnia and Herzegovina
Therapeutic groupRespiratory system (R02AA06)
Marketing authorization holderBOSNALIJEK D.D. PREDSTAVNIŠTVO CRNA GORA
Authorization dateMarch 9, 2026

Analogs in Montenegro

11

Other medicines with the same active substance

LYSOBACTOTC
Compressed lozenge, 20mg/10mgBosnalijek d.d.
LYSOBACT SPRAY® SA AROMOM PEPERMINTAOTC
Oromucosal spray, solution, 20mg/ml +1.5mg/mlBosnalijek d.d.
SEPTOLETE TOTALOTC
Oromucosal spray, solution, 1.5mg/ml + 5mg/mlKrka d.d.
SEPTOLETE TOTAL COLAOTC
Lozenge, 3mg + 1mgKrka d.d.
SEPTOLETE TOTAL EUKALIPTUSOTC
Lozenge, 3mg + 1mgKrka d.d.
SEPTOLETE TOTAL EUKALIPTUSOTC
Lozenge, 3mg + 1mgKrka d.d.
SEPTOLETE TOTAL LIMUN I ĐUMBIROTC
Lozenge, 3mg + 1mgKrka d.d.
SEPTOLETE TOTAL LIMUN I MEDOTC
Lozenge, 3mg + 1mgKrka d.d.
SEPTOLETE TOTAL LIMUN I MEDOTC
Lozenge, 3mg + 1mgKrka d.d.
SEPTOLETE TOTAL LIMUN I ZOVAOTC
Lozenge, 3mg + 1mgKrka d.d.
SEPTOLETE TOTAL LIMUN I ZOVAOTC
Lozenge, 3mg + 1mgKrka d.d.
Source: CInMED register